Skip to main content
Log in

Molecular Imaging of Cell Death in an Experimental Model of Parkinson’s Disease with a Novel Apoptosis-Targeting Peptide

  • ResearcH Article
  • Published:
Molecular Imaging and Biology Aims and scope Submit manuscript

Abstract

Purpose

We used a novel apoptosis-targeting peptide called ApoPep-1 in order to evaluate whether ApoPep-1 can be used as a diagnostic indicator in a model of Parkinson’s disease (PD).

Procedures

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was given to mice to produce the PD model. Cy7.5-labeled ApoPep-1 was given intravenously and optical imaging was taken at 1, 2, and 3 weeks after MPTP treatment. Immunohistochemical study was performed with brain sections.

Results

Increased ApoPep-1 signal was observed in the brain of MPTP-treated mice by in vivo and ex vivo imaging study. With histological evaluation, ApoPep-1 signal demonstrated a strong correlation with loss of dopaminergic neurons or increase of apoptotic cells. Moreover, the neuroprotective effect of amantadine in the MPTP model was effectively evaluated using optical imaging of ApoPep-1.

Conclusions

We conclude that ApoPep-1 is the effective probe for imaging of apoptosis in the MPTP model and can be applied in brain diseases with apoptosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

PD:

Parkinson’s disease

SNpc:

Substantia nigra parts compacta

MPTP:

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

TUNEL:

Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay

DNA:

Deoxyribonucleic acid

PBS:

Phosphate-buffered saline

BSA:

Bovine serum albumin

TH:

Tyrosine hydroxylase

References

  1. von Bohlen Und Halbach O (2005) Modeling neurodegenerative diseases in vivo review. Neurodegener Dis 2(6):313–320

    Article  Google Scholar 

  2. George JL, Mok S, Moses D et al (2009) Targeting the progression of Parkinson’s disease. Curr Neuropharmacol 7(1):9–36

    Article  PubMed  CAS  Google Scholar 

  3. Naoi M, Maruyama W, Yi H et al (2009) Mitochondria in neurodegenerative disorders: regulation of the redox state and death signaling leading to neuronal death and survival. J Neural Transm 116(11):1371–1381

    Article  PubMed  CAS  Google Scholar 

  4. Winklhofer KF, Haass C (2010) Mitochondrial dysfunction in Parkinson’s disease. Biochim Biophys Acta 1802(1):29–44

    PubMed  CAS  Google Scholar 

  5. Levy OA, Malagelada C, Greene LA (2009) Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps. Apoptosis 14(4):478–500

    Article  PubMed  Google Scholar 

  6. Tatton WG, Chalmers-Redman R, Brown D, Tatton N (2003) Apoptosis in Parkinson’s disease: signals for neuronal degradation. Ann Neurol 53(Suppl 3):S61–S70, discussion S70–72

    Article  PubMed  CAS  Google Scholar 

  7. Tait JF (2008) Imaging of apoptosis. J Nucl Med 49(10):1573–1576

    Article  PubMed  Google Scholar 

  8. Smith G, Nguyen QD, Aboagye EO (2009) Translational imaging of apoptosis. Anticancer Agents Med Chem 9(9):958–967

    PubMed  CAS  Google Scholar 

  9. Blankenberg FG (2008) In vivo detection of apoptosis. J Nucl Med 49(Suppl 2):81S–95S

    Article  PubMed  CAS  Google Scholar 

  10. De Saint-Hubert M, Prinsen K, Mortelmans L, Verbruggen A, Mottaghy FM (2009) Molecular imaging of cell death. Methods 48(2):178–187

    Article  PubMed  Google Scholar 

  11. Fischer K, Voelkl S, Berger J et al (2006) Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells. Blood 108(13):4094–4101

    Article  PubMed  CAS  Google Scholar 

  12. Smrz D, Draberova L, Draber P (2007) Non-apoptotic phosphatidylserine externalization induced by engagement of glycosylphosphatidylinositol-anchored proteins. J Biol Chem 282(14):10487–10497

    Article  PubMed  CAS  Google Scholar 

  13. Wang K, Purushotham S, Lee JY et al (2010) In vivo imaging of tumor apoptosis using histone H1-targeting peptide. J Control Release 148(3):283–291

    Article  PubMed  CAS  Google Scholar 

  14. Dauer W, Przedborski S (2003) Parkinson’s disease: mechanisms and models. Neuron 39(6):889–909

    Article  PubMed  CAS  Google Scholar 

  15. Schapira AH (2010) Complex I: inhibitors, inhibition and neurodegeneration. Exp Neurol 224(2):331–335

    Article  PubMed  CAS  Google Scholar 

  16. Bredesen DE, Rao RV, Mehlen P (2006) Cell death in the nervous system. Nature 443(7113):796–802

    Article  PubMed  CAS  Google Scholar 

  17. Jenner P, Olanow CW (2006) The pathogenesis of cell death in Parkinson’s disease. Neurology 66(10 Suppl 4):S24–S36

    PubMed  Google Scholar 

  18. Liang CL, Wang TT, Luby-Phelps K, German DC (2007) Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson’s disease. Exp Neurol 203(2):370–380

    Article  PubMed  CAS  Google Scholar 

  19. Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson’s disease: a target for neuroprotection? Lancet Neurol 8(4):382–397

    Article  PubMed  CAS  Google Scholar 

  20. Novikova L, Garris BL, Garris DR, Lau YS (2006) Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson’s disease. Neuroscience 140(1):67–76

    Article  PubMed  CAS  Google Scholar 

  21. Ruiz-Vela A, Korsmeyer SJ (2007) Proapoptotic histone H1.2 induces CASP-3 and -7 activation by forming a protein complex with CYT c, APAF-1 and CASP-9. FEBS Lett 581(18):3422–3428

    Article  PubMed  CAS  Google Scholar 

  22. Ohsawa S, Hamada S, Yoshida H, Miura M (2008) Caspase-mediated changes in histone H1 in early apoptosis: prolonged caspase activation in developing olfactory sensory neurons. Cell Death Differ 15(9):1429–1439

    Article  PubMed  CAS  Google Scholar 

  23. Reis J, John D, Heimeroth A et al (2006) Modulation of human motor cortex excitability by single doses of amantadine. Neuropsychopharmacology 31(12):2758–2766

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This work was supported by grant no. RTI04-01-01 from the Regional Technology Innovation Program of the Ministry of Knowledge Economy (MKE) & Converging Research Center Program through the Ministry of Education, Science and Technology (2010K001054).

Conflict of Interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Byung-Heon Lee or Hyung Soo Han.

Electronic Supplementary Materials

Below is the link to the electronic supplementary material.

ESM 1

(PDF 1203 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, MJ., Wang, K., Kim, IS. et al. Molecular Imaging of Cell Death in an Experimental Model of Parkinson’s Disease with a Novel Apoptosis-Targeting Peptide. Mol Imaging Biol 14, 147–155 (2012). https://doi.org/10.1007/s11307-011-0497-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11307-011-0497-z

Key words

Navigation